Decipher Adaptive Immunity  

Investigate antigen-specific immune cells with Dextramer® reagents for flow cytometry and beyond

Study the Antigen-Specific Immune Response

Dextramer® technology enables you to get the complete picture of the antigen-specific cellular immune response.

Push the boundaries of your research with high-quality products and services designed to discover, detect and characterize antigen-specific T and B cells, non-conventional T cells, antigen-presenting cells, CAR cells and more.

Discover

Achieve Unrivaled Results

Flow Cytometry

Sensitively quantify target immune cells by flow cytometry with a strong signal-to-noise ratio. 

Read More

Single-Cell Multi-Omics

Discover and characterize antigen-specific immune cells at single-cell resolution.

Read More

TCR Discovery

Advance the development of novel T cell therapies through TCR discovery.

Read More

GMP Reagents

Dextramer® GMP reagents for lot-release testing of T cell therapies.

Read More

Immune Cell Stimulation

Antigen-specific activation of immune cells with  Xynapse™ technology. 

Read more

Maximize the Potential of Cellular Immunotherapies

Discover the range of immune cell therapies including TCR-T and CAR-T. Explore how Dextramer® and Xynapse™ technologies can support the development of cell therapies.

Discover

More Effective Cancer Vaccines

Leverage the full armory of the cellular immune response in vaccine development. Discover how Dextramer® technology can elucidate variation and persistence of antigen-specific T and B cell responses.

Discover

You Define the Challenge

We offer custom solutions and services tailored to your needs - unique Dextramer® products for unique research applications.

Discover

Empowering Breakthrough Research Worldwide

"Quick and timely delivery of products, good customer support, prompt responses to product-related queries"

Scientist, Pharmaceutical Company
"I have already recommended Immudex reagents to current and former colleagues because I am satisfied with the quality of the products and the customer support"

Scientist, Pharmaceutical Company
"As a company that develops targeted immunotherapies, we have used Dextramer® reagents in our preclinical development and clinical trials. Based on this, we view Immudex as a reliable partner and can attest to the consistent quality they provide"

Kerry Sieger, M.A., VP of Global Quality Operations, Immatics​

Join our Newsletter

We keep you inspired with the newest scientific papers and case studies.

Subscribe Here

Contact Us – Let’s Talk Science

Connect with our immune monitoring experts to discuss your experiments.